News

VIEW ALL

Feldan Therapeutics Announces a Publication in Nature Communications

October 28, 2019

Feldan Therapeutics honored at the 2019 ANGES QUÉBEC ANNUAL RENDEZ-VOUS

June 14, 2019

Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics, to improve a novel intracellular delivery technology

June 4, 2019

New Corporate Identity for Feldan Therapeutics

February 8, 2019

François-Thomas Michaud recipient of the Visionary Entrepreneur of the Year Award

December 5, 2018

FELDAN THERAPEUTICS ANNOUNCES ADDITIONAL INVESTMENT IN SERIES A

Québec City, Canada, November 27, 2018 – Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in...

November 27, 2018

FELDAN THERAPEUTICS IS PROUD TO SUPPORT THE 2019TH EDITION OF THE ANNUAL CRISPR CONFERENCE

We are proud partner of the CRISPR congress 2019 to be held in Québec City, June 17-20, 2019. This annual event provides an...

November 14, 2018

UNIVERSITY OF IOWA AND FELDAN THERAPEUTICS AWARDED GRANT BY THE NATIONAL INSTITUTES OF HEALTH

University of Iowa and Feldan Therapeutics awarded grant by the National Institutes of Health

Quebec City, Canada, October 12, 2018 –

October 12, 2018

FELDAN THERAPEUTICS RAISES $12.5 MILLION IN SERIES A FINANCING ROUND

QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions...

September 18, 2018

GC LABCELL AND FELDAN THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP NEXT-GENERATION NK CELLS FOR IMMUNOTHERAPY USING FELDAN SHUTTLE TECHNOLOGY

Seoul (South Korea) & Québec City (Canada) June 27, 2018 – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”)...

June 27, 2018